- Home
- CVM vs ASRT Comparison
CVM vs ASRT Comparison
Compare CVM & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVM
- ASRT
- Stock Information
- Founded
- CVM 1983
- ASRT 1995
- Country
- CVM United States
- ASRT United States
- Employees
- CVM N/A
- ASRT N/A
- Industry
- CVM Biotechnology: Biological Products (No Diagnostic Substances)
- ASRT Biotechnology: Pharmaceutical Preparations
- Sector
- CVM Health Care
- ASRT Health Care
- Exchange
- CVM Nasdaq
- ASRT Nasdaq
- Market Cap
- CVM 71.2M
- ASRT 79.1M
- IPO Year
- CVM 1987
- ASRT 1997
- Fundamental
- Price
- CVM $9.91
- ASRT $0.81
- Analyst Decision
- CVM
- ASRT Strong Buy
- Analyst Count
- CVM 0
- ASRT 1
- Target Price
- CVM N/A
- ASRT $3.00
- AVG Volume (30 Days)
- CVM 294.7K
- ASRT 178.0K
- Earning Date
- CVM 08-14-2025
- ASRT 11-10-2025
- Dividend Yield
- CVM N/A
- ASRT N/A
- EPS Growth
- CVM N/A
- ASRT N/A
- EPS
- CVM N/A
- ASRT N/A
- Revenue
- CVM N/A
- ASRT $117,099,000.00
- Revenue This Year
- CVM N/A
- ASRT N/A
- Revenue Next Year
- CVM N/A
- ASRT $5.84
- P/E Ratio
- CVM N/A
- ASRT N/A
- Revenue Growth
- CVM N/A
- ASRT N/A
- 52 Week Low
- CVM $1.98
- ASRT $0.51
- 52 Week High
- CVM $38.70
- ASRT $1.38
- Technical
- Relative Strength Index (RSI)
- CVM 51.86
- ASRT 52.12
- Support Level
- CVM N/A
- ASRT N/A
- Resistance Level
- CVM $10.48
- ASRT $0.83
- Average True Range (ATR)
- CVM 1.11
- ASRT 0.03
- MACD
- CVM -0.64
- ASRT -0.03
- Stochastic Oscillator
- CVM 73.74
- ASRT 92.14
About CVM Cel-Sci Corporation
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.